STAT4 (rs7574865) Polymorphism and Serum STAT4 Levels in Rheumatoid Arthritis Susceptibility, Severity, and Treatment Response: A Case-Control Study in Iraqi Patients

Document Type : Original Research

Authors

Department of Laboratory Investigations, Faculty of Science, University of Kufa, Najaf, Iraq

Abstract
Background & Objective: Signal Transducer and Activator of Transcription 4 (STAT4) is a key transcription factor involved in immune signaling pathways and has been implicated in susceptibility to rheumatoid arthritis (RA) across various populations. However, its role in Iraqi Arab cohorts remains largely unexplored.
Methods: A case–control study was conducted including 68 RA patients and 39 age- and sex-matched apparently healthy individuals. The association between the STAT4 (rs7574865) polymorphism, serum STAT4 levels, RA susceptibility, and therapeutic response to methotrexate (MTX), MTX + infliximab, and tofacitinib was investigated using PCR–RFLP and ELISA techniques.
Results: The frequencies of the GT and (GT+TT) genotypes were significantly higher among RA patients than in controls under codominant and dominant models (P = .003 and P < .001, respectively). The T allele was also significantly more frequent in RA patients than in healthy individuals (P = .001). GT and TT genotypes were significantly associated with severe disease (P = .042) and poor response to tofacitinib compared with the GG genotype (P = .042). Serum STAT4 levels were markedly elevated in RA patients compared with controls (P = .01), particularly in those with severe RA (P = .042).
Conclusion: The STAT4 rs7574865 T allele may contribute to increased susceptibility to RA, greater disease severity, and reduced responsiveness to tofacitinib therapy in Iraqi patients.

Keywords

Subjects


  1. Yang B, Zhao H, Zhao Y, Liu F, Zhang L. STAT4 gene polymorphism and rheumatoid arthritis in Chinese Han population: A case-control study and meta-analysis. BMC Med Genomics. 2022; 15(1):126. [DOI:10.1186/s12920-022-01177-7]
  2. Almutairi N, Almutairi M, Alanazi M, Parine NR. Impact of STAT4 rs7574865 polymorphism on autoimmune disease susceptibility in Middle Eastern populations: A systematic review and meta-analysis. Genes (Basel). 2023;14(1):85. [DOI:10.3390/genes14010085]
  3. Gao W, Dong X, Yang Z, Mao G, Xing W. Association between rs7574865 polymorphism in STAT4 gene and rheumatoid arthritis: An updated meta-analysis. Eur J Intern Med. 2020;71:101-3. [DOI:10.1016/j.ejim.2019.11.009] [PMID]
  4. Zayed KS, Kudhair BK, Lafta IJ. Association of CTLA-4 (+49A/G) polymorphism and susceptibility of developing rheumatoid arthritis in an Iraqi Arab population. Hum Gene. 2022; 33:201037. [DOI:10.1016/j.humgen.2022.201037]
  5. Li Y, Zhang K, Chen L, Zeng L, Du Y, Wang X, et al. Association between STAT4 rs7574865 polymorphism and rheumatoid arthritis: An updated meta-analysis. Int Immunopharmacol. 2021;99:107988. [DOI:10.1016/j.intimp.2021.107988]
  6. Wang L, Zhang Y, Huang H, Zheng L, Zhang J, Xu W. Serum STAT4 expression in rheumatoid arthritis and its clinical significance. Immunol Res. 2020;68(3):178-86. [DOI:10.1007/s12026-020-09127-0]
  7. Bravo-Villagra KM, Domínguez-Mancilla A, Bernal JA, Velarde-Félix JS. STAT4 gene variant rs7574865 is associated with rheumatoid arthritis activity and anti-CCP levels in the western but not in the southern population of Mexico. Genes (Basel). 2024;15(2):241. [DOI:10.3390/genes15020241] [PMID] [PMCID]
  8. Esparza Guerrero Y, Palafox-Sánchez CA, Muñoz-Valle JF, Salgado-Bustamante M. Association of the STAT4 gene rs7574865 polymorphism with IFN-γ levels in patients with systemic lupus erythematosus. Genes (Basel). 2023;14(3):537. doi:10.3390/genes14030537 [DOI:10.3390/genes14030537] [PMID] [PMCID]
  9. Palomino-Morales RJ, Rojas-Villarraga A, González CI, Ramírez G, Anaya JM, Martín J. STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Genes Immun. 2008;9(4):379-82. [DOI:10.1038/gene.2008.30] [PMID]
  10. Tarakji I, Habbal W, Monem F. Association Between STAT4 rs7574865 Polymorphism and Rheumatoid Arthritis: Debate Unresolved. Open Rheumatol J. 2018;12:172-8. [PMID] [PMCID] [DOI:10.2174/1874312901812010172]
  11. Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007;357(10):977-86. [DOI:10.1056/NEJMoa073003] [PMID] [PMCID]
  12. Kawasaki A, Ito I, Hikami K, Ohashi J, Hayashi T, Goto D, et al. Association of STAT4 with rheumatoid arthritis in a Japanese population. Ann Rheum Dis. 2008;67(3):428-9. [DOI:10.1136/ard.2007.075192]
  13. Zayed KS, Alhakeem MA, Alkaabi ZS. Vitamin D receptor gene polymorphisms in Iraqi Arab children with autism spectrum disorder and serum vitamin D and vitamin D receptor levels. Hum Gene. 2023;37:201192. [DOI:10.1016/j.humgen.2023.201192]
  14. Migita K, Nakamura M, Abiru S, Jiuchi Y, Nagaoka S, Komori A, et al. Association of STAT4 polymorphisms with susceptibility to type-1 autoimmune hepatitis in the Japanese population. PLoS One. 2013;8(8):e71382. [PMID] [PMCID] [DOI:10.1371/journal.pone.0071382]
  15. Shen L, Liu R, Zhang H, Huang Y, Sun R, Tang P. Replication study of STAT4 rs7574865 G/T polymorphism and risk of rheumatoid arthritis in a Chinese population. Gene. 2013;526(2):259-264. [DOI:10.1016/j.gene.2013.05.022] [PMID]
  16. El-Saadany HM, Amer WH, Khalil HS, Gaber RA, Elshweikh SA. Association of STAT4 polymorphism with susceptibility and severity of rheumatoid arthritis and systemic lupus erythematosus in Egyptian patients. The Egyptian Rheumatologist. 2016;38(1):21-7. [DOI:10.1016/j.ejr.2015.04.003]
  17. Zayed KS, Kudhair BK, Aziz DZ, Lafta IJ. The G allele of the ADAM33 T1 polymorphism (rs2280091) is a risk factor associated with asthma severity among the Iraqi Arab population. Hum Gene. 2023;36:201181. [DOI:10.1016/j.humgen.2023.201181]
  18. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum. 1993;36(6):729-740. [DOI:10.1002/art.1780360601] [PMID]
  19. Van der Heijde DM, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol. 1993;20(3):579-581.
  20. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-47. [DOI:10.1016/j.ejca.2008.10.026] [PMID]
  21. Tong G, Zhang X, Tong W, Liu Y. Association between polymorphism in STAT4 gene and risk of rheumatoid arthritis: a meta-analysis. Hum. Immunol. 2013;74(5):586-92. [DOI:10.1016/j.humimm.2012.11.033] [PMID]
  22. Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Association between the rs7574865 polymorphism of STAT4 and rheumatoid arthritis: a meta-analysis. Rheumatol Int. 2010;30(5):661-6. [DOI:10.1007/s00296-009-1051-z] [PMID]
  23. Ebrahimiyan H, Mostafaei S, Aslani S, Jamshidi A, Mahmoudi M. Studying the association between STAT4 gene polymorphism and susceptibility to rheumatoid arthritis disease: An updated meta-analysis. Iran J Immunol. 2019; 16(1):71-83. [DOI:10.1016/j.mgene.2018.03.010]
  24. Lamana A, Balsa A, Rueda B, Ortiz AM, Nuno L, Miranda-Carus ME. The TT genotype of the STAT4 rs7574865 polymorphism is associated with high disease activity and disability in patients with early arthritis. PLoS One. 2012;7(8):e43661. [DOI:10.1371/journal.pone.0043661] [PMID] [PMCID]
  25. Xia Y, Xie Y, Zhang H, Liu L. STAT4 gene polymorphisms in human diseases. Front Immunol. 2024;15:1479418. [PMID] [PMCID] [DOI:10.3389/fimmu.2024.1479418]
  26. Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23(5):S100.
  27. Nomair AM, Abdelati A, Dwedar FI, Elnemr R, Kamel YN, Nomeir HM. The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients. Clin Rheumatol. 2024;43(3):971-983. [PMID] [PMCID] [DOI:10.1007/s10067-024-06892-w]
  28. Saeed, I. M., Tarkhany, A., Hama, Y., & Al-Shatri, S. (2023). Environmental considerations, sustainability opportunities and Iraqi government's energy policies: a comparative study. Environment, Development and Sustainability, 25(7), 6879-6895.‏ [DOI:10.1007/s10668-022-02339-x]
  29. Mikhaylenko DS, Nemtsova MV, Bure IV, Kuznetsova EB. Genetic polymorphisms associated with rheumatoid arthritis development and antirheumatic therapy response. Int J Mol Sci. 2020;21(14):4911. [DOI:10.3390/ijms21144911] [PMID] [PMCID]
  30. El-Lebedy D, Raslan H, Ibrahim A, Ashmawy I, Abd El-Aziz S, El-Mazary A. Association of STAT4 rs7574865 and PTPN22 rs2476601 polymorphisms with rheumatoid arthritis and non-systemically reacting antibodies in Egyptian patients. Clinc. Rheumat. 2017; 36(9), 1981-1987. [DOI:10.1007/s10067-017-3632-7] [PMID]
  31. Wang Y, Chen W, Zhu Y, Xu D, Lu Q, Wu A. STAT4 rs7574865 polymorphism contributes to rheumatoid arthritis susceptibility: Evidence from 40 studies. Autoimmun Rev. 2020;19(4):102504. [DOI:10.1016/j.autrev.2020.102504]
  32. Li X, Zhang L, Liu J, Wang Y, Chen Y, Zhao Q. Association of serum STAT4 levels with disease activity in rheumatoid arthritis. Clin Rheumatol. 2019;38(9):2513-2519. [DOI:10.1007/s10067-019-04563-2]
  33. Choi JY, Lee SH, Kim MJ, Park JH, Kang SW, Kim EK. Elevated STAT4 expression in PBMCs of rheumatoid arthritis patients contributes to Th1/Th17 imbalance. Autoimmunity. 2021; 54(2):123-130. [DOI:10.1080/08916934.2020.1843969]
Volume 20, Issue 4
Summer 2025
Pages 421-430

  • Receive Date 03 May 2025
  • Revise Date 06 June 2025
  • Accept Date 21 July 2025